부신 CT 검사에서 HU의 조영증강 및 선량 평가

Evaluation of Contrast Enhancement of HU and Effective Dose for Adrenal MDCT

  • 권대철 (신한대학교 바이오생태보건대학 방사선학과) ;
  • 최지원 (전주대학교 방사선학과)
  • Kweon, Dae Cheol (Department of Radiological Science, College of Bioecological Health, Shinhan University) ;
  • Choi, Jiwon (Department of Radiological Sciences, Jeonju University)
  • 투고 : 2018.03.25
  • 심사 : 2018.06.21
  • 발행 : 2018.06.30

초록

The purpose is to improve the accuracy of dose reduction and adrenal gland diagnosis by analyzing the HU and evaluating the effective dose of contrast CT scan of the adrenal gland in order to evaluate the accuracy of contrast enhancement of adrenal adenomas. We analyzed the dose information of patient DICOM file that underwent CT scan of adrenal gland examination. CT scan of the adrenal gland performed pre contrast, portal phase, a 3 minute delay and a 15 minute delay. The HU measurement selects the largest region of adrenal lesion. And, mean, standard deviation, and area of the adrenal lesion were analyzed by ROI. Absolute percentage washout (APW) and relative percentage washout (RPW) calculated and the adrenal adenomas diagnosed by threshold value of the percentage washout rate were above APW 60% and RPW 40%. Effective dose was calculated based on DLP of DICOM dose report for adrenal CT scan. HU analyzed of the adrenal gland by calculating APW and RPW. The APW and RPW were analyzed by 52% and 41.8% at 3 minute delay, 73.5% and 59% at 15 minute delay, respectively. The diagnosis of adrenal adenomas was consistent with APW (73.5%) and RPW (59%) above the threshold at 15 minute delay. The effective dose of adrenal CT scan was 16.08 mSv. Therefore, it is necessary for radiation dose reduction.

키워드

참고문헌

  1. Angelelli G, Mancini ME, Moschetta M, Pedote P, Pignataro P and Scardapane A. 2013. MDCT in the differentiation of adrenal masses: comparison between different scan delays for the evaluation of intralesional washout. Scientific World J. 2013:957680.
  2. Blake MA, Kalra MK, Sweeney AT, Lucey BC, Maher MM, Sahani DV, Halpern EF, Mueller PR, Hahn PF and Boland GW. 2006. Distinguishing benign from malignant adrenal masses: multi-detector row CT protocol with 10-minute delay. Radiology 238(2):578-585. https://doi.org/10.1148/radiol.2382041514
  3. Boland GW, Lee MJ, Gazelle GS, Halpern EF, McNicholas MM and Mueller PR. 1998. Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature. AJR Am. J. Roentgenol. 171:201-204 https://doi.org/10.2214/ajr.171.1.9648789
  4. Caoili EM, Korobkin M, Francis IR, Cohan RH, Platt JF, Dunnick NR and Raghupathi KI. 2002. Adrenal masses: characterization with combined unenhanced and delayed enhanced CT. Radiology 22:629-633.
  5. Choyke PL. 2006. ACR appropriateness criteria on incidentally discovered adrenal mass. J. Am. Coll. Radiol. 3(7):498-504. https://doi.org/10.1016/j.jacr.2006.02.031
  6. Christner JA, Kofler JM and McCollough CH. 2010. Estimating effective dose for CT using dose-length product compared with using organ doses: consequences of adopting International Commission on Radiological Protection publication 103 or dual-energy scanning. AJR Am. J. Roentgenol. 194(5):881-889. https://doi.org/10.2214/AJR.09.3462
  7. Deak PD, Smal Y and Kalender WA. 2010. Multisection CT protocols: sex- and age-specific conversion factors used to determine effective dose from dose-length product. Radiology 257(1):158-166. https://doi.org/10.1148/radiol.10100047
  8. Dunnick NR and Korobkin M. 2002. Imaging of adrenal incidentalomas: current status. AJR Am. J. Roentgenol. 179:559-568. https://doi.org/10.2214/ajr.179.3.1790559
  9. Gervaise A, Osemont B, Louis M, Lecocq S, Teixeria P and Blum A. 2014. Standard dose versus low-dose abdominal and pelvic CT: Comparison between filtered back projection versus adaptive iterative dose reduction 3D. Dign. Interv. Imaging. 95(1):47-53. https://doi.org/10.1016/j.diii.2013.05.005
  10. Johnson PT, Horton KM and Fishman EK. 2009. Adrenal imaging with multidetector CT: evidence-based protocol optimization and interpretative practice. Radiographics 29(5):1319-1331. https://doi.org/10.1148/rg.295095026
  11. Kloos RT, Gross MD, Francis IR, Korobkin M and Shapiro B. 1995. Incidentally discovered adrenal masses. Endocr. Rev. 16:460-484.
  12. Korobkin M, Brodeur FJ, Yutzy GG, Francis IR, Quint LE, Dunnick NR and Kazerooni EA. 1996. Differentiation of adrenal adenomas from nonadenomas using CT attenuation values. AJR Am. J. Roentgenol. 166(3):531-536. https://doi.org/10.2214/ajr.166.3.8623622
  13. Kweon DC, Dong KR, Jung JE and Ryu YH. 2009. Comparison radiation dose with upper and lower Limbs of automated injection of contrast media with a bolus tracking system in pulmonary embolism MDCT. J. Radiat. Indt. 3(4):323-328
  14. Park TS, Han JH, Jo SY, Lee EL, Jo KW and Kweon DC. 2017. Comparison of Noise and Doses of Low Dose and High Resolution Chest CT for Automatic Tube Current Modulation and Fixed Tube Current Technique using Glass Dosimetry. J. Radiat. Indt. 11(3):131-137.
  15. Pena CS, Boland GW, Hahn PF, Lee MJ and Mueller PR. 2000. Characterization of indeterminate (lipid-poor) adrenal masses: use of washout characteristics at contrast-enhanced CT. Radiology 217:798-802. https://doi.org/10.1148/radiology.217.3.r00dc29798
  16. Sohn KM, Lee SY and Lee KH. 2003. Usefulness of Percentage Enhancement Washout Value Calculated on Unenhanced, Contrast-Enhanced, and Delayed Enhanced CT in Adrenal Masses: Adenoma versus Metastasis. J. Korean Radiol. Soc. 48:427-432. https://doi.org/10.3348/jkrs.2003.48.5.427
  17. Szolar DH and Kammerhuber FH. 1998. Adrenal adenomas and nonadenomas: assessment of washout at delayed contrast-enhanced CT. Radiology 207:369-375. https://doi.org/10.1148/radiology.207.2.9577483
  18. Takahashi Y, Ota H, Omura K, Dendo Y, Otani K, Matsuura T, Kitami M, Seiji K, Tezuka Y, Nezu M, Ono Y, Morimoto R, Satoh F and Takase K. 2018. Image quality and radiation dose of low-tube-voltage CT with reduced contrast media for right adrenal vein imaging. Eur J Radiol. 98:150-157. https://doi.org/10.1016/j.ejrad.2017.11.017